Elizabeth R Woodruff
13PUBLICATIONS
56CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (13)
Sort by Publication Date:
|Jan 24, 2026
Chromobox2 inhibition: a novel activity of alisertib, an aurora A kinase inhibitor.Tomomi M Yamamoto, Ritsuko Iwanaga, Elizabeth R Woodruff
|Dec 04, 2025
SM08502-Mediated β-Catenin Repression Synergizes with Olaparib to Inhibit Tumor Progression.Bradley R Corr, Elizabeth R Woodruff, Tomomi M Yamamoto
|Dec 03, 2024
Claudin-4 Stabilizes the Genome via Nuclear and Cell-Cycle Remodeling to Support Ovarian Cancer Cell Survival.Fabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda
|Sep 16, 2024
Claudin-4 remodeling of nucleus-cell cycle crosstalk maintains ovarian tumor genome stability and drives resistance to genomic instability-inducing agents.Fabian R Villagomez, Julie Lang, Daniel Nunez-Avellaneda
|Aug 13, 2024
EHMT1/2 Inhibition Promotes Regression of Therapy-Resistant Ovarian Cancer Tumors in a CD8 T-cell-Dependent Manner.Lily L Nguyen, Zachary L Watson, Raquel Ortega
|Jul 10, 2024
Tumor-Intrinsic Activity of Chromobox 2 Remodels the Tumor Microenvironment in High-grade Serous Carcinoma.Ritsuko Iwanaga, Tomomi M Yamamoto, Karina Gomez
Pageof 3
Frequent Collaborators
13 joint publications
Benjamin G Bitler
7 joint publications
Tomomi M Yamamoto
5 joint publications
Kian Behbakht
5 joint publications
Lily L Nguyen
5 joint publications
Ritsuko Iwanaga
5 joint publications
Kimberly R Jordan
4 joint publications
Fabian R Villagomez
4 joint publications
Edward B Chuong
3 joint publications
Margaret Neville
3 joint publications
Miriam D Post
